PlatformMethodologyRolesGovernanceAnalysisAIAdoption Request a demo
Corporate sales planning & S&OP platform

One single system for sales planning and the S&OP process

FIRO structures the preparation, review and approval of sales forecasts within a single environment. Planning information stays consolidated and traceable, and the process runs in a governed, consistent way.

Consolidated, consistent planning information
Structured end-to-end approval flow
Up to 10 simulation scenarios in parallel
FIRO · Dashboard P&LRead only
Net Sales
$ 48,6 M
▲ 6,4% vs Budget
Margin
42,0%
▲ 1,2 pts
Units
1,24 M
▼ 2,1%
Actual ForecastPlan S&OP · 2026

A single planning process spans every stage, from the initial version to final approval.

Traceable

Every figure keeps its source, its author and its change history.

Collaborative

Planning, Demand and Supply Chain work on the same baseline.

Auditable

Versions, approvals and assumptions are recorded permanently.

Consolidated

The official projection lives in a single system, with integrated information and no parallel copies.

Proven in demanding planning environments. Its S&OP process model applies to consumer goods, distribution, healthcare and industry.

The planning challenge

Running planning and budgeting on scattered spreadsheets is hard to control and audit

S&OP aligns commercial projections with operational capacity and the organization’s financial goals. Sustaining that process on scattered files makes it fragile.

Fragmented information

Multiple copies of the same number, with no way to know which is official.

No traceability

You can’t reconstruct who changed what, or why.

Informal approvals

Approvals happen by email or verbally, with no record.

No version control

Scenarios and assumptions overwrite each other and get lost.

Platform capabilities

An end-to-end platform for the entire planning cycle

FIRO consolidates demand projection, scenario management and financial analysis in a single environment, bringing into one orderly process what is solved today with spreadsheets, emails and disconnected tools.

Forecast

Editable grid to plan month by month by product, channel and version. Automatic limit checks, copy & paste from Excel and a read-only analytical view.

Versions

The control center of the cycle. Each version is a complete scenario —Forecast, Budget, operating plan or ad-hoc— with the option to carry the base period from one cycle to the next.

Master Data

The single source that feeds all planning: channels, SKU catalog, inventory, multi-currency exchange rates, prices, costs, increments, discounts and actuals.

Dashboard P&L

A P&L financial dashboard that turns the forecast into results, comparing projection against actuals and versions against each other, in a read-only view.

Dashboard BI

Advanced multidimensional analysis on the same data, to compare versions side by side and examine deviations against budget with depth and agility.

Bulk data import

Load large data volumes through predefined templates, with background processing that keeps the operation smooth during import.

The platform in action

A tour of FIRO

The same screens the planning team works with, on sample data.

FIRO · HomeLabModelo
FIRO — Home
SKU · Product catalog5 families · 43 SKUs
Status
Code
Description
Brand
Family
UM1
UM2
Actions
Active
9000002
Hematron 25 mg
Hematron
Hematology
1
0,001
Active
9000003
Hematron 50 mg
Hematron
Hematology
1
0,005
Active
9000004
Adelvia 5 mg
Adelvia
Metabolism
1
0,000054
Active
9000005
Endocrest 20 mg
Endocrest
Endocrinology
1
0,0015
Active
9000007
Hormonex 2 0.5 mg/mL
Hormonex 2
Endocrinology
1
0,0018
Active
9000008
Glucenta 1 mg/mL
Glucenta
Cardiometabolism
1
0,000004
A single catalog of products, brands, families and units of measure.
Price listsBUD26ARS
SKU
Version
Year
Month
Base price
IIBB
Net price
Actions
Cardiolex 1 mg/mL
BUD26
2026
Jan
155.718
2,5%
151.825
Glucenta 1 mg/mL
BUD26
2026
Jan
134.265
2,5%
130.908
Glargivia 2
BUD26
2026
Jan
115.325
2,5%
112.442
Hormonex 2
BUD26
2026
Jan
209.188
2,5%
203.958
Sangrelix 10 mg
BUD26
2026
Jan
1.153.420
5,0%
1.095.749
Respivia 50 mg
BUD26
2026
Jan
627.399
2,5%
611.714
Prices by version, year and month, with taxes, monthly increments and discounts.
FC2601ConstrainedNon-PAMIHematology
SKU
Channel
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Hematron 25 mg
Non-PAMI
267
257
248
238
238
226
214
Hematron 50 mg
Non-PAMI
299
287
282
278
276
271
271
Sangrelix 15 mg
Non-PAMI
640
645
645
650
650
650
661
Sangrelix 10 mg
Non-PAMI
785
791
794
802
808
814
820
Plasmia 200 UI
Non-PAMI
40
40
40
40
40
40
10
Coagulen 50 mg
Non-PAMI
1.776
1.763
1.757
1.752
1.760
1.749
1.742
The first 3 columns are Actual; the rest is projected · copy & paste from Excel.
Workflow — BUD26
Active version · Step 3 of 8
1
OpeningFinance
2
ForecastProduct Manager
3
BU ReviewBU Director
4
StockSupply Chain
5
PricingPricing
6
UnitsFinance
7
FinancialFinance
8
ApprovalGeneral Manager
Sequential approvals, with an owner and a record for every step.
PVM · Price Volume MixFC2602 vs BUD26ARSUSD2026
Budget → Forecast bridge · Net Sales (ARS, Bn)
271 +190 −60 +16 417 BUD26 Volume Price Mix FC2602
Trend · Budget vs Forecast (2026)
Jan Jun Dec
Budget Forecast
Price-volume-mix bridge and trend comparing versions (Budget vs Forecast).
Methodology

A governed process from start to finish

Eight sequential steps, with defined owners and validations that ensure every decision moves forward on approved data.

1
Finance

Open the version

Opens the cycle and enables data entry for the rest of the participants.

2
Product Manager

Forecast entry

Completes the projection for their product family and sends it to the BU Director.

3
BU Director

Business unit review

Approves or rejects; requires approval from both business units.

4
Supply Chain

Stock validation

Validates feasibility against inventory and adjusts stock and forecast.

5
Pricing

Price review

Reviews and adjusts price lists to secure margins; approval only.

6
Finance

Unit consistency

Checks the consistency of projected units against budget.

7
Finance

Financial impact

Assesses the effect on revenue, costs, margins and P&L.

8
General Manager

Final approval

Final review: their decision closes the cycle or restarts it.

Lock after approval

Once a step is approved, lower-tier users cannot change their data. The only way to reopen it is a rejection by the upper validator.

Parallel steps

Once both business units are approved, the Supply Chain and Pricing stages move in parallel, shortening cycle time without losing control.

Roles & collaboration

Every owner, in their role and within their scope

Six defined profiles that collaborate on a single version, each with permissions scoped to their responsibility.

FI

Finance

Broadest scope and unrestricted access: manages the version lifecycle and the financial evaluation of the plan.

JP

Product Manager (JP)

Enters the projections for the assigned product family; their involvement is limited to the Forecast.

UN

BU Director

Reviews and decides on what their business unit submitted, without changing the data.

LO

Supply Chain

Validates feasibility against stock and adjusts inventory and forecast where needed.

PR

Pricing

Reviews and adjusts price lists to secure margins; their action is approval.

DG

General Manager

Last reviewer in the flow: closes the cycle or restarts it with their final decision.

Each user accesses only what pertains to them based on their product family or business unit, keeping information scoped and the process orderly.
Multi-scenario planning

Planning structured around formal scenarios

Uncertainty is inherent to any commercial projection. FIRO structures planning around formal scenarios that coexist within each version without interfering with one another, keeping the traceability of every hypothesis and the ability to compare them directly.

10

Up to five upside and five downside scenarios per version: ten alternative situations modeled at the same time, without altering the base plan data.

Required

Potential demand

Demand with no stock constraints, revealing the full market potential.

Required

Constrained plan

The plan adjusted to real inventory constraints. The base scenario of every version.

Hasta ×5

Downside scenarios

The conservative view that quantifies downside risks, on top of the base scenario.

Hasta ×5

Upside scenarios

The effect of extraordinary commercial efforts —tenders, launches— added on top of the base scenario.

From demand to the bottom line

From planned units to the income statement

FIRO automatically walks the chain that links demand projection to the income statement, giving full traceability from the unit to the margin.

1

Planned units

The projections entered month by month by product, channel and scenario form the basis of the calculation.

2

Valuation

Each unit is multiplied by its price and adjusted with increments, compound discounts and taxes.

3

Multi-currency conversion

Values are expressed in the analysis currency by applying the defined exchange rates.

4

Cost matching

The valued revenue is matched against product costs to obtain Net Sales.

5

Margin & P&L

The difference between Net Sales and cost determines the margin, comparable across versions and against actuals.

Governance & control

Control and traceability in every decision of the cycle

FIRO builds governance into the heart of the process. Permissions, edit locks and validations operate automatically as the cycle advances, and every action is recorded with its author, its timing and its context. The organization keeps consolidated information and full control over the data and its deployment.

  • Role-based access controlEach user operates only within the scope and permissions defined for their profile.
  • Lock after approvalOnce a stage is approved, its data is protected and only reopens with a rejection from the upper validator.
  • Automatic validationsMinimum and maximum limits are checked automatically, and deletions require explicit confirmation.
  • Audit and history logEvery approval is logged: who acted, what they decided, when and with what comments.
  • Integrated dataThe app, the P&L and the BI dashboard run on integrated data, with no parallel versions.
  • Your data under controlThe platform is your own: the data, authentication and deployment stay under the organization’s control.
Analysis & decision

Financial and business analysis on integrated information

The P&L dashboard and the BI dashboard read exactly the same information as the planning operation. No reconciliations or intermediate exports: what gets approved is what gets analyzed.

  • Forecast vs. Actual and comparison across versions, month by month.
  • Deviations against budget broken down by business unit, brand and channel.
  • Multidimensional analysis in BI on the same governed data.
FIRO · Version analysisBI
Dashboard BIFC2602 vs BUD26ARSUSD
Net Sales
$ 416.979 M
Units
3,65 M
Margin
84%
Net Sales by family · ARS (M)
Endocrinology222.476
Metabolism60.444
Hematology53.937
Cardiometab.49.302
Respiratory30.821
Mix by business unit
62% Primary
Primary Care 62% Specialty Care 38%
Artificial intelligence

Artificial intelligence that audits the projection, it doesn’t replace it

Artificial intelligence doesn’t generate the plan: it reviews it. It evaluates forecast accuracy, detects anomalies and highlights the deviations that deserve attention, so the team can decide with better information.

Forecast accuracy

Measures how accurate the projections are against actuals and their evolution by period, product and channel.

Anomaly detection

Identifies atypical entries, unexpected jumps and out-of-pattern values before they advance through the approval flow.

Projection analysis

Highlights the relevant deviations against budget and across versions, focusing on what needs review.

The decision always belongs to the team: AI provides analytical insight and alerts, it doesn’t automate judgment.

Adoption

A gradual, orderly rollout

FIRO replaces the mix of spreadsheets, emails and manual processes —or complements existing ERPs— with a platform designed for the S&OP process. Adoption is gradual, without losing the knowledge already built around the process.

1

Assessment and setup

The process and master data are assessed, and product families, business units and roles are configured to match the organization’s structure.

2

Data migration

Historical and current information is moved from the current sources into a common, consolidated repository.

3

Go-live

Roles and the eight-step workflow are enabled, and the team starts running the cycle with full governance and traceability.

Request a demo.

FIRO centralizes the preparation, review and approval of your sales forecasts in a governed S&OP process. Request a demo and we’ll walk it through with your scenarios.